Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.

Authors :: Ching THW
Amoroso L
Bohner C
D'Amico E
Eilbott J
Entezar T
Fitzpatrick M
Fram G
Grazioplene R
Hokanson J
Jankovsky A
Kichuk SA
Martins B
Patel P
Schaer H
Shnayder S
Witherow C
Pittenger C
Kelmendi B
Source :: Frontiers in psychiatry [Front Psychiatry] 2024 Feb 16; Vol. 15, pp. 1372373. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Publication Year :: 2024
Abstract: [This corrects the article DOI: 10.3389/fpsyt.2023.1278823.].<br /> (Copyright © 2024 Ching, Amoroso, Bohner, D'Amico, Eilbott, Entezar, Fitzpatrick, Fram, Grazioplene, Hokanson, Jankovsky, Kichuk, Martins, Patel, Schaer, Shnayder, Witherow, Pittenger and Kelmendi.)

Full Text Access

Tools